Wednesday, February 10, 2010, 7:09am EST - Canadian Markets open in 2 hours and 21 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Gen-Probe Inc. (GPRO)

On Feb 9: 43.19 USD   0.00 (0.00%)  
MORE ON GPRO
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Gen-Probe Incorporated (NasdaqNM:GPRO) Delayed quote dataEdit
Last Trade: 43.19 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 43.19
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 75.33
Day's Range: N/A - N/A
52wk Range: 35.70 - 49.29
Volume: 0
Avg Vol (3m): 313,781
Market Cap: 2.12B
P/E (ttm): 28.16
EPS (ttm): 1.53
Div & Yield: N/A (N/A%)
Gen-Probe Inc. (GPRO)
1d  5d  3m  6m  1y  2y  5y  max 
 Add GPRO to Portfolio   Download Data

HEADLINES
Molecular Diagnostics Industry Creates New Sector With High Growth And Rapid Valuation Formation Characteristics For Investors According To Industry Expert
Wall Street Transcript (Wed, Jan 27)
An In-Depth Look At Diagnostics Companies And Stock Evaluations From Dr. Ashim Anand Of Natixis Bleichroeder, LLC
Wall Street Transcript (Mon, Jan 25)
Coverage initiated on Gen-Probe by Jefferies & Co
Briefing.com (Thu, Jan 21)
Gen-Probe Earnings Call scheduled for Thu, Feb 18
CCBN (Thu, Jan 14)
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2009 Earnings Conference Call
Business Wire (Thu, Jan 14)
Gen-Probe to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference
PRNewswire (Tue, Jan 5)
Neogen Beats by a Penny
Zacks.com (Tue, Dec 22)
Neogen 2Q profit rises on food safety sales
AP (Fri, Dec 18)
4-Star Stocks on the Upswing
at Motley Fool (Wed, Dec 16)
GEN PROBE INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Dec 15)
Technical Setups: Frontline, Gen-Probe
at TheStreet.com (Tue, Dec 15)
More Headlines for GPRO...

ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : 1.70
Avg Rec (current)*: 1.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Gen-Probe Incorporated develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, screening donated human blood, and detection of harmful organisms in the environment and in industrial ...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices